Test description
Testing (next generation sequencing) for IDH1 variants in tumour tissue in patients with histologically confirmed cholangiocarcinoma.
Test information
Test name
IDH1
Clinical indication
Testing for patients with histologically confirmed cholangiocarcinoma. Information from this test may assist in determining suitability for treatment with targeted therapies.
Gene(s)
IDH1
Method
NGS Oncomine Precision Assay
Turn around time
1 week from receipt of sample
Medicare eligibility
73319 criteria apply
Price
If not MBS eligible. Please contact 1800 822 999 for pricing details
Test request form
Standard pathology request form
Sample type
FFPE Tumour Tissue
Collection type
N/A
Special instructions
6 x 5 micron slides plus 1 x H&E stained slide required
FAQ
No items found.
Resources
No items found.